Latest Industry Insights

Discover how crowdfunding could help biotech startups and cell and gene therapy developers overcome funding barriers by engaging patients, physicians and everyday investors.

Learn how the Amperia platform improves AAV quantification accuracy and speed, making gene therapy development more accessible and consistent.

Explore the dosing challenges posed by current gene therapies and how circular RNA may unlock more potent and safer therapies.

Dr. Heidi Rehm shares insights on how genomics is evolving at the intersection of research and clinical practice. In this Q&A, she highlights the role of AI, global data standards and collaboration in shaping future patient care.

Families with rare diseases often wait years for answers. GeneDx’s AI-driven dataset, Infinity™, is changing that. In this interview, Dr. Bryan Dechario explains how decades of data are reshaping the future of genomic medicine.

Deep Visual Proteomics integrates high-resolution imaging, AI and ultra-sensitive mass spectrometry to map proteins at single-cell resolution while preserving spatial context.

Explore the unique issues of rare disease trials and how “gene silencing” therapies could reshape the future for patients with H-ABC.

ELRIG Drug Discovery 2025 recognizes BubbleFect, a lipid-free cell delivery system that utilizes phase separation peptides for non-viral gene therapy delivery.

In this interview, we explore how single-cell technologies, automation and strategic partnerships are shaping the future of cancer immunotherapy.

Discover how one of the biggest biopharma acquisitions of 2025 aims to expand rare tumor therapies for hard-to-treat cancers like desmoid tumors.